Biomarin Pharmaceutical (BMRN) Q1 2026 Earnings

25FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.28
0.22
0.73
1.23

Details

Expected EPS
0.207
Actual EPS
N/A
Surprise EPS
-0.21
Surprise Percent
+100%

Description

Biomarin Pharmaceutical (BMRN) will report earnings of for Q1 2026 on February 25, 2026.

0 Comments

Share your thoughts